HMGB1 and cancer: Cancer cells undergoing ICD contribute to the emission of immuno-stimulatory molecules, such as damage-associated molecular patterns (DAMPs), the most common of which are ATP, high-mobility group box 1 (HMGB1), and calreticulin (CRT) [3,6,7,8].